bibliographicCitation |
Yi H, Ye X, Long B, Ye T, Zhang L, Yan F, Yang Y, Li L. Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer. Cancer Biotherapy and Radiopharmaceuticals. 2017 Jun;32(5):176–83. doi: 10.1089/cbr.2017.2187. |